Vitagenix

HD Labs Retatrutide 32mg Vial

Triple-action metabolic support in a flexible 32mg vial format. Retatrutide is an investigational triple agonist (GLP-1/GIP/glucagon) studied for weight loss and blood sugar control. Not an approved treatment — supplied on an informed-purchaser basis.

• ·Cost-effective 32mg retatrutide vial format for flexible protocols
• ·Triple-agonist support across GLP-1, GIP and glucagon receptors
• ·Designed for metabolic reset, appetite control and fat loss
• ·Investigational profile targeting glucose, energy and body composition
• ·Supplied on an informed-purchaser basis — consult a healthcare provider first

For advanced users targeting significant fat loss.